Wednesday, July 8, 2026

pharma · Gastroesophageal Reflux · Migraine · ADXN

Addex Therapeutics

Addex Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

GENEVA, V8, CH HQ
2002 Founded
21 Employees
Public company Type
ADXN · NYSE Ticker
Company details
Status
Public
HQ
GENEVA, V8, CH
Founded
2002
Employees
21
Programs
6
Drugs
3
Patents
40
Intelligence · Clinical Programs

Addex Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Addex Therapeutics.

Addex Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ADX48621

    Addex Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Addex Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.